A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)
Palo Alto (17 mi)Age: 18 - 65
Sex: Male
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 1
Waitlist Available
Sponsor: Merck Sharp & Dohme LLC
No Placebo Group
Trial Summary
What is the purpose of this trial?The purpose of this study is to learn what happens to enlicitide chloride labeled with \[¹⁴C\] in a person's body over time. A label can be added to a study medicine to trace it in a person's body.
Eligibility Criteria
Treatment Details
1Treatment groups
Experimental Treatment
Group I: [¹⁴C]Enlicitide chlorideExperimental Treatment1 Intervention
Participants will receive a single dose of \[¹⁴C\]enlicitide chloride on Day 1.
Find a clinic near you
Research locations nearbySelect from list below to view details:
Labcorp Clinical Research Unit Inc. (Site 0001)Madison, WI
Loading ...
Who is running the clinical trial?
Merck Sharp & Dohme LLCLead Sponsor